Thursday, July 9, 2015

Biologic Advancements for Psoraisis



Biologic agents over the past 15 years have offered new freedom to people living with psoriasis. These protein molecules administered under the skin decrease the inflammatory response that is created in the skin and cause psoriasis.

Written by Dr. Jerry Bagel
Two treatments in particular Humira and Stelara can improve an individual's psoriasis by75%, 75% of the time.  Furthermore it can improve psoriasis 90%.  Half of the time Humira is administered every other week at home by the patient, whereas Stelara is administered every 12 weeks in the office. 

The most common risk associated with the administration of biologic agents is a 1-2 % increase in infections requiring antibiotic therapy.  Although there has been fear that biologic agents increase the frequency of cancer, both short and long term safety data do not reveal an increase in cancer when biologic agents are used.  

If you are interested in learning more about biologic agents, how they work and what type might be best for you call our office at 609-443-4500.